nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—CHRND—pericardium—lung cancer	0.0588	0.582	CbGeAlD
Rocuronium—Respiratory insufficiency—Pemetrexed—lung cancer	0.0273	0.077	CcSEcCtD
Rocuronium—Injection site swelling—Paclitaxel—lung cancer	0.0125	0.0354	CcSEcCtD
Rocuronium—CHRNA2—mammary gland—lung cancer	0.0116	0.115	CbGeAlD
Rocuronium—CHRND—respiratory system—lung cancer	0.0112	0.111	CbGeAlD
Rocuronium—Respiratory failure—Crizotinib—lung cancer	0.00919	0.0259	CcSEcCtD
Rocuronium—Respiratory failure—Pemetrexed—lung cancer	0.00839	0.0237	CcSEcCtD
Rocuronium—Respiratory failure—Gefitinib—lung cancer	0.00834	0.0235	CcSEcCtD
Rocuronium—Myopathy—Erlotinib—lung cancer	0.00698	0.0197	CcSEcCtD
Rocuronium—CHRND—lung—lung cancer	0.00595	0.0589	CbGeAlD
Rocuronium—Muscular weakness—Crizotinib—lung cancer	0.00578	0.0163	CcSEcCtD
Rocuronium—Cardiovascular disorder—Erlotinib—lung cancer	0.00557	0.0157	CcSEcCtD
Rocuronium—HTR3A—respiratory system—lung cancer	0.00555	0.0549	CbGeAlD
Rocuronium—Respiratory failure—Topotecan—lung cancer	0.00504	0.0142	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Paclitaxel—lung cancer	0.00435	0.0123	CcSEcCtD
Rocuronium—Respiratory failure—Vinorelbine—lung cancer	0.00431	0.0122	CcSEcCtD
Rocuronium—Bronchospasm—Teniposide—lung cancer	0.00412	0.0116	CcSEcCtD
Rocuronium—Arrhythmia—Crizotinib—lung cancer	0.00405	0.0114	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Topotecan—lung cancer	0.00371	0.0105	CcSEcCtD
Rocuronium—Arrhythmia—Pemetrexed—lung cancer	0.0037	0.0104	CcSEcCtD
Rocuronium—Arrhythmia—Gefitinib—lung cancer	0.00367	0.0104	CcSEcCtD
Rocuronium—Hiccups—Irinotecan—lung cancer	0.00349	0.00985	CcSEcCtD
Rocuronium—Respiratory failure—Gemcitabine—lung cancer	0.00346	0.00977	CcSEcCtD
Rocuronium—Apnoea—Etoposide—lung cancer	0.00343	0.00967	CcSEcCtD
Rocuronium—Cardiovascular disorder—Etoposide—lung cancer	0.00331	0.00933	CcSEcCtD
Rocuronium—Hiccups—Cisplatin—lung cancer	0.00317	0.00894	CcSEcCtD
Rocuronium—Shock—Crizotinib—lung cancer	0.00317	0.00893	CcSEcCtD
Rocuronium—Hypertension—Pemetrexed—lung cancer	0.00311	0.00878	CcSEcCtD
Rocuronium—Wheezing—Cisplatin—lung cancer	0.00308	0.00869	CcSEcCtD
Rocuronium—Arrhythmia—Teniposide—lung cancer	0.003	0.00845	CcSEcCtD
Rocuronium—HTR3A—lung—lung cancer	0.00294	0.0291	CbGeAlD
Rocuronium—Anaphylactic shock—Pemetrexed—lung cancer	0.00294	0.0083	CcSEcCtD
Rocuronium—Respiratory failure—Paclitaxel—lung cancer	0.0029	0.00818	CcSEcCtD
Rocuronium—Shock—Pemetrexed—lung cancer	0.00289	0.00816	CcSEcCtD
Rocuronium—Shock—Gefitinib—lung cancer	0.00288	0.00811	CcSEcCtD
Rocuronium—Wheezing—Paclitaxel—lung cancer	0.00277	0.0078	CcSEcCtD
Rocuronium—Hypotension—Gefitinib—lung cancer	0.00273	0.0077	CcSEcCtD
Rocuronium—Muscular weakness—Vinorelbine—lung cancer	0.00271	0.00765	CcSEcCtD
Rocuronium—CHRNB1—lymph node—lung cancer	0.00262	0.0259	CbGeAlD
Rocuronium—Anaphylactoid reaction—Irinotecan—lung cancer	0.00262	0.00739	CcSEcCtD
Rocuronium—Bronchospasm—Vinorelbine—lung cancer	0.00261	0.00737	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Gemcitabine—lung cancer	0.00255	0.0072	CcSEcCtD
Rocuronium—Hypertension—Teniposide—lung cancer	0.00252	0.00711	CcSEcCtD
Rocuronium—Paralysis—Methotrexate—lung cancer	0.0025	0.00706	CcSEcCtD
Rocuronium—Respiratory failure—Docetaxel—lung cancer	0.00246	0.00693	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Cisplatin—lung cancer	0.00238	0.00671	CcSEcCtD
Rocuronium—Tachycardia—Teniposide—lung cancer	0.00233	0.00656	CcSEcCtD
Rocuronium—SLCO1A2—lung—lung cancer	0.00232	0.023	CbGeAlD
Rocuronium—Hypotension—Teniposide—lung cancer	0.00223	0.00628	CcSEcCtD
Rocuronium—Arrhythmia—Erlotinib—lung cancer	0.0022	0.0062	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Etoposide—lung cancer	0.00218	0.00615	CcSEcCtD
Rocuronium—Paralysis—Doxorubicin—lung cancer	0.00217	0.00612	CcSEcCtD
Rocuronium—Hypersensitivity—Pemetrexed—lung cancer	0.00217	0.00611	CcSEcCtD
Rocuronium—Hypersensitivity—Gefitinib—lung cancer	0.00215	0.00607	CcSEcCtD
Rocuronium—Bronchospasm—Gemcitabine—lung cancer	0.0021	0.00592	CcSEcCtD
Rocuronium—Pruritus—Pemetrexed—lung cancer	0.00208	0.00587	CcSEcCtD
Rocuronium—Pruritus—Gefitinib—lung cancer	0.00207	0.00583	CcSEcCtD
Rocuronium—Apnoea—Methotrexate—lung cancer	0.00205	0.00579	CcSEcCtD
Rocuronium—Vomiting—Crizotinib—lung cancer	0.00205	0.00577	CcSEcCtD
Rocuronium—Rash—Crizotinib—lung cancer	0.00203	0.00572	CcSEcCtD
Rocuronium—Dermatitis—Crizotinib—lung cancer	0.00203	0.00572	CcSEcCtD
Rocuronium—Hypertension—Vinblastine—lung cancer	0.00192	0.00542	CcSEcCtD
Rocuronium—Nausea—Crizotinib—lung cancer	0.00191	0.00539	CcSEcCtD
Rocuronium—Arrhythmia—Vinorelbine—lung cancer	0.0019	0.00536	CcSEcCtD
Rocuronium—Vomiting—Pemetrexed—lung cancer	0.00187	0.00528	CcSEcCtD
Rocuronium—Vomiting—Gefitinib—lung cancer	0.00186	0.00524	CcSEcCtD
Rocuronium—Rash—Pemetrexed—lung cancer	0.00185	0.00523	CcSEcCtD
Rocuronium—Dermatitis—Pemetrexed—lung cancer	0.00185	0.00523	CcSEcCtD
Rocuronium—Rash—Gefitinib—lung cancer	0.00184	0.0052	CcSEcCtD
Rocuronium—Dermatitis—Gefitinib—lung cancer	0.00184	0.00519	CcSEcCtD
Rocuronium—Muscular weakness—Paclitaxel—lung cancer	0.00182	0.00514	CcSEcCtD
Rocuronium—Bronchospasm—Etoposide—lung cancer	0.00179	0.00506	CcSEcCtD
Rocuronium—Respiratory failure—Methotrexate—lung cancer	0.00177	0.005	CcSEcCtD
Rocuronium—Anaphylactic shock—Topotecan—lung cancer	0.00177	0.00498	CcSEcCtD
Rocuronium—Hypersensitivity—Teniposide—lung cancer	0.00176	0.00495	CcSEcCtD
Rocuronium—Nausea—Pemetrexed—lung cancer	0.00175	0.00493	CcSEcCtD
Rocuronium—Nausea—Gefitinib—lung cancer	0.00174	0.0049	CcSEcCtD
Rocuronium—Shock—Erlotinib—lung cancer	0.00172	0.00485	CcSEcCtD
Rocuronium—Cardiovascular disorder—Doxorubicin—lung cancer	0.00171	0.00484	CcSEcCtD
Rocuronium—Pruritus—Teniposide—lung cancer	0.00169	0.00475	CcSEcCtD
Rocuronium—Hypertension—Vinorelbine—lung cancer	0.0016	0.00451	CcSEcCtD
Rocuronium—Arrhythmia—Irinotecan—lung cancer	0.00157	0.00442	CcSEcCtD
Rocuronium—Arrhythmia—Gemcitabine—lung cancer	0.00153	0.0043	CcSEcCtD
Rocuronium—Vomiting—Teniposide—lung cancer	0.00151	0.00427	CcSEcCtD
Rocuronium—Anaphylactic shock—Vinorelbine—lung cancer	0.00151	0.00426	CcSEcCtD
Rocuronium—Hiccups—Doxorubicin—lung cancer	0.00151	0.00425	CcSEcCtD
Rocuronium—Rash—Teniposide—lung cancer	0.0015	0.00424	CcSEcCtD
Rocuronium—Dermatitis—Teniposide—lung cancer	0.0015	0.00423	CcSEcCtD
Rocuronium—Bronchospasm—Docetaxel—lung cancer	0.00149	0.0042	CcSEcCtD
Rocuronium—Tachycardia—Vinorelbine—lung cancer	0.00147	0.00416	CcSEcCtD
Rocuronium—Arrhythmia—Cisplatin—lung cancer	0.00142	0.00401	CcSEcCtD
Rocuronium—Nausea—Teniposide—lung cancer	0.00142	0.00399	CcSEcCtD
Rocuronium—Hypotension—Vinorelbine—lung cancer	0.00141	0.00398	CcSEcCtD
Rocuronium—Hypersensitivity—Vinblastine—lung cancer	0.00134	0.00378	CcSEcCtD
Rocuronium—Hypertension—Irinotecan—lung cancer	0.00132	0.00372	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Methotrexate—lung cancer	0.0013	0.00368	CcSEcCtD
Rocuronium—Hypersensitivity—Topotecan—lung cancer	0.0013	0.00367	CcSEcCtD
Rocuronium—Hypertension—Gemcitabine—lung cancer	0.00128	0.00362	CcSEcCtD
Rocuronium—Arrhythmia—Paclitaxel—lung cancer	0.00128	0.0036	CcSEcCtD
Rocuronium—Pruritus—Topotecan—lung cancer	0.00125	0.00352	CcSEcCtD
Rocuronium—Anaphylactic shock—Irinotecan—lung cancer	0.00125	0.00351	CcSEcCtD
Rocuronium—Pruritus—Erlotinib—lung cancer	0.00124	0.00349	CcSEcCtD
Rocuronium—Shock—Irinotecan—lung cancer	0.00123	0.00346	CcSEcCtD
Rocuronium—Anaphylactic shock—Gemcitabine—lung cancer	0.00121	0.00342	CcSEcCtD
Rocuronium—Hypotension—Irinotecan—lung cancer	0.00116	0.00328	CcSEcCtD
Rocuronium—Vomiting—Vinblastine—lung cancer	0.00116	0.00326	CcSEcCtD
Rocuronium—Hypotension—Gemcitabine—lung cancer	0.00113	0.0032	CcSEcCtD
Rocuronium—Anaphylactic shock—Cisplatin—lung cancer	0.00113	0.00319	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00113	0.00319	CcSEcCtD
Rocuronium—Vomiting—Topotecan—lung cancer	0.00112	0.00317	CcSEcCtD
Rocuronium—Rash—Topotecan—lung cancer	0.00111	0.00314	CcSEcCtD
Rocuronium—Hypersensitivity—Vinorelbine—lung cancer	0.00111	0.00314	CcSEcCtD
Rocuronium—Dermatitis—Topotecan—lung cancer	0.00111	0.00314	CcSEcCtD
Rocuronium—Vomiting—Erlotinib—lung cancer	0.00111	0.00313	CcSEcCtD
Rocuronium—Tachycardia—Cisplatin—lung cancer	0.0011	0.00311	CcSEcCtD
Rocuronium—Rash—Erlotinib—lung cancer	0.0011	0.00311	CcSEcCtD
Rocuronium—Dermatitis—Erlotinib—lung cancer	0.0011	0.0031	CcSEcCtD
Rocuronium—Hypertension—Etoposide—lung cancer	0.0011	0.00309	CcSEcCtD
Rocuronium—Asthma—Methotrexate—lung cancer	0.00109	0.00308	CcSEcCtD
Rocuronium—Arrhythmia—Docetaxel—lung cancer	0.00108	0.00305	CcSEcCtD
Rocuronium—Nausea—Vinblastine—lung cancer	0.00108	0.00305	CcSEcCtD
Rocuronium—Hypertension—Paclitaxel—lung cancer	0.00107	0.00303	CcSEcCtD
Rocuronium—Pruritus—Vinorelbine—lung cancer	0.00107	0.00301	CcSEcCtD
Rocuronium—Hypotension—Cisplatin—lung cancer	0.00106	0.00298	CcSEcCtD
Rocuronium—Nausea—Topotecan—lung cancer	0.00105	0.00296	CcSEcCtD
Rocuronium—Nausea—Erlotinib—lung cancer	0.00104	0.00293	CcSEcCtD
Rocuronium—Anaphylactic shock—Etoposide—lung cancer	0.00104	0.00292	CcSEcCtD
Rocuronium—Anaphylactic shock—Paclitaxel—lung cancer	0.00102	0.00287	CcSEcCtD
Rocuronium—Tachycardia—Etoposide—lung cancer	0.00101	0.00285	CcSEcCtD
Rocuronium—Shock—Paclitaxel—lung cancer	0.001	0.00282	CcSEcCtD
Rocuronium—Tachycardia—Paclitaxel—lung cancer	0.000992	0.0028	CcSEcCtD
Rocuronium—Hypotension—Etoposide—lung cancer	0.000968	0.00273	CcSEcCtD
Rocuronium—Muscular weakness—Doxorubicin—lung cancer	0.000964	0.00272	CcSEcCtD
Rocuronium—Vomiting—Vinorelbine—lung cancer	0.00096	0.00271	CcSEcCtD
Rocuronium—Rash—Vinorelbine—lung cancer	0.000952	0.00269	CcSEcCtD
Rocuronium—Dermatitis—Vinorelbine—lung cancer	0.000951	0.00268	CcSEcCtD
Rocuronium—Hypotension—Paclitaxel—lung cancer	0.000949	0.00268	CcSEcCtD
Rocuronium—Asthma—Doxorubicin—lung cancer	0.000945	0.00267	CcSEcCtD
Rocuronium—Hypersensitivity—Irinotecan—lung cancer	0.000918	0.00259	CcSEcCtD
Rocuronium—Hypertension—Docetaxel—lung cancer	0.000911	0.00257	CcSEcCtD
Rocuronium—Nausea—Vinorelbine—lung cancer	0.000897	0.00253	CcSEcCtD
Rocuronium—Anaphylactic shock—Docetaxel—lung cancer	0.000861	0.00243	CcSEcCtD
Rocuronium—Pruritus—Gemcitabine—lung cancer	0.000859	0.00242	CcSEcCtD
Rocuronium—Shock—Docetaxel—lung cancer	0.000847	0.00239	CcSEcCtD
Rocuronium—Tachycardia—Docetaxel—lung cancer	0.00084	0.00237	CcSEcCtD
Rocuronium—Hypersensitivity—Cisplatin—lung cancer	0.000833	0.00235	CcSEcCtD
Rocuronium—Hypotension—Docetaxel—lung cancer	0.000805	0.00227	CcSEcCtD
Rocuronium—Vomiting—Irinotecan—lung cancer	0.000792	0.00223	CcSEcCtD
Rocuronium—Rash—Irinotecan—lung cancer	0.000785	0.00222	CcSEcCtD
Rocuronium—Dermatitis—Irinotecan—lung cancer	0.000785	0.00221	CcSEcCtD
Rocuronium—Vomiting—Gemcitabine—lung cancer	0.000772	0.00218	CcSEcCtD
Rocuronium—Rash—Gemcitabine—lung cancer	0.000765	0.00216	CcSEcCtD
Rocuronium—Dermatitis—Gemcitabine—lung cancer	0.000764	0.00216	CcSEcCtD
Rocuronium—Hypersensitivity—Etoposide—lung cancer	0.000763	0.00215	CcSEcCtD
Rocuronium—Hypersensitivity—Paclitaxel—lung cancer	0.000749	0.00211	CcSEcCtD
Rocuronium—Nausea—Irinotecan—lung cancer	0.00074	0.00209	CcSEcCtD
Rocuronium—Pruritus—Etoposide—lung cancer	0.000733	0.00207	CcSEcCtD
Rocuronium—Nausea—Gemcitabine—lung cancer	0.000721	0.00203	CcSEcCtD
Rocuronium—Vomiting—Cisplatin—lung cancer	0.000719	0.00203	CcSEcCtD
Rocuronium—Pruritus—Paclitaxel—lung cancer	0.000719	0.00203	CcSEcCtD
Rocuronium—Rash—Cisplatin—lung cancer	0.000713	0.00201	CcSEcCtD
Rocuronium—Dermatitis—Cisplatin—lung cancer	0.000712	0.00201	CcSEcCtD
Rocuronium—Arrhythmia—Doxorubicin—lung cancer	0.000676	0.00191	CcSEcCtD
Rocuronium—Nausea—Cisplatin—lung cancer	0.000672	0.0019	CcSEcCtD
Rocuronium—Vomiting—Etoposide—lung cancer	0.000659	0.00186	CcSEcCtD
Rocuronium—Rash—Etoposide—lung cancer	0.000653	0.00184	CcSEcCtD
Rocuronium—Dermatitis—Etoposide—lung cancer	0.000653	0.00184	CcSEcCtD
Rocuronium—Vomiting—Paclitaxel—lung cancer	0.000646	0.00182	CcSEcCtD
Rocuronium—Rash—Paclitaxel—lung cancer	0.000641	0.00181	CcSEcCtD
Rocuronium—Dermatitis—Paclitaxel—lung cancer	0.00064	0.00181	CcSEcCtD
Rocuronium—Hypersensitivity—Docetaxel—lung cancer	0.000634	0.00179	CcSEcCtD
Rocuronium—Anaphylactic shock—Methotrexate—lung cancer	0.000621	0.00175	CcSEcCtD
Rocuronium—Nausea—Etoposide—lung cancer	0.000615	0.00174	CcSEcCtD
Rocuronium—Pruritus—Docetaxel—lung cancer	0.000609	0.00172	CcSEcCtD
Rocuronium—Nausea—Paclitaxel—lung cancer	0.000603	0.0017	CcSEcCtD
Rocuronium—Hypotension—Methotrexate—lung cancer	0.00058	0.00164	CcSEcCtD
Rocuronium—Hypertension—Doxorubicin—lung cancer	0.000569	0.0016	CcSEcCtD
Rocuronium—Vomiting—Docetaxel—lung cancer	0.000548	0.00154	CcSEcCtD
Rocuronium—Rash—Docetaxel—lung cancer	0.000543	0.00153	CcSEcCtD
Rocuronium—Dermatitis—Docetaxel—lung cancer	0.000542	0.00153	CcSEcCtD
Rocuronium—Anaphylactic shock—Doxorubicin—lung cancer	0.000537	0.00152	CcSEcCtD
Rocuronium—Shock—Doxorubicin—lung cancer	0.000529	0.00149	CcSEcCtD
Rocuronium—Tachycardia—Doxorubicin—lung cancer	0.000525	0.00148	CcSEcCtD
Rocuronium—Nausea—Docetaxel—lung cancer	0.000512	0.00144	CcSEcCtD
Rocuronium—Hypotension—Doxorubicin—lung cancer	0.000502	0.00142	CcSEcCtD
Rocuronium—Hypersensitivity—Methotrexate—lung cancer	0.000457	0.00129	CcSEcCtD
Rocuronium—Pruritus—Methotrexate—lung cancer	0.000439	0.00124	CcSEcCtD
Rocuronium—Hypersensitivity—Doxorubicin—lung cancer	0.000396	0.00112	CcSEcCtD
Rocuronium—Vomiting—Methotrexate—lung cancer	0.000395	0.00111	CcSEcCtD
Rocuronium—Rash—Methotrexate—lung cancer	0.000391	0.0011	CcSEcCtD
Rocuronium—Dermatitis—Methotrexate—lung cancer	0.000391	0.0011	CcSEcCtD
Rocuronium—Pruritus—Doxorubicin—lung cancer	0.00038	0.00107	CcSEcCtD
Rocuronium—Nausea—Methotrexate—lung cancer	0.000369	0.00104	CcSEcCtD
Rocuronium—Vomiting—Doxorubicin—lung cancer	0.000342	0.000964	CcSEcCtD
Rocuronium—Rash—Doxorubicin—lung cancer	0.000339	0.000956	CcSEcCtD
Rocuronium—Dermatitis—Doxorubicin—lung cancer	0.000339	0.000955	CcSEcCtD
Rocuronium—Nausea—Doxorubicin—lung cancer	0.000319	0.000901	CcSEcCtD
Rocuronium—SLCO1A2—Metabolism—GSTA4—lung cancer	0.000116	0.000214	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM2—lung cancer	0.000115	0.000212	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CNDP2—lung cancer	0.000115	0.000212	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—POMC—lung cancer	0.000115	0.000211	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—JUN—lung cancer	0.000115	0.000211	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—HRAS—lung cancer	0.000114	0.000209	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000114	0.000209	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTA2—lung cancer	0.000113	0.000208	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTMR3—lung cancer	0.000112	0.000206	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AXL—lung cancer	0.00011	0.000203	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTA1—lung cancer	0.000109	0.000201	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PGAM1—lung cancer	0.000109	0.000201	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—OXTR—lung cancer	0.000109	0.0002	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRP—lung cancer	0.000109	0.0002	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—HRAS—lung cancer	0.000108	0.000199	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCC3—lung cancer	0.000108	0.000199	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—BRAF—lung cancer	0.000108	0.000199	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—EP300—lung cancer	0.000106	0.000194	CbGpPWpGaD
Rocuronium—SLC22A1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000106	0.000194	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKR1C1—lung cancer	0.000105	0.000192	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—AVP—lung cancer	0.000105	0.000192	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2A7—lung cancer	0.000104	0.000192	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—NRAS—lung cancer	0.000103	0.000189	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNG11—lung cancer	0.000102	0.000188	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SDC4—lung cancer	0.000102	0.000187	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—UGT1A1—lung cancer	0.000102	0.000187	CbGpPWpGaD
Rocuronium—Vecuronium—ABCB1—lung cancer	0.000102	1	CrCbGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.0001	0.000184	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—OXTR—lung cancer	9.91e-05	0.000182	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRP—lung cancer	9.91e-05	0.000182	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—lung cancer	9.84e-05	0.000181	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GNG11—lung cancer	9.81e-05	0.00018	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.76e-05	0.000179	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—lung cancer	9.36e-05	0.000172	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALDOA—lung cancer	9.34e-05	0.000172	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—RRM1—lung cancer	9.29e-05	0.000171	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTA3—lung cancer	9.29e-05	0.000171	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—APOA1—lung cancer	9.28e-05	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNG11—lung cancer	9.28e-05	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ADCY1—lung cancer	9.19e-05	0.000169	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	9.14e-05	0.000168	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NCOA3—lung cancer	9.07e-05	0.000167	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—MDM2—lung cancer	9.06e-05	0.000166	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—RAF1—lung cancer	9.03e-05	0.000166	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.91e-05	0.000164	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—CXCL8—lung cancer	8.89e-05	0.000163	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—AVP—lung cancer	8.86e-05	0.000163	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—KRAS—lung cancer	8.84e-05	0.000162	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ADCY1—lung cancer	8.82e-05	0.000162	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCG2—lung cancer	8.82e-05	0.000162	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—B4GALT5—lung cancer	8.74e-05	0.000161	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ENO2—lung cancer	8.65e-05	0.000159	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HPGDS—lung cancer	8.65e-05	0.000159	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PPP2R1B—lung cancer	8.6e-05	0.000158	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—lung cancer	8.58e-05	0.000158	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—COL4A2—lung cancer	8.58e-05	0.000158	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PTHLH—lung cancer	8.54e-05	0.000157	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTA4—lung cancer	8.5e-05	0.000156	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.48e-05	0.000156	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTT1—lung cancer	8.39e-05	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GIPR—lung cancer	8.36e-05	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADCY1—lung cancer	8.34e-05	0.000153	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2A6—lung cancer	8.29e-05	0.000152	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GCLC—lung cancer	8.29e-05	0.000152	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTA2—lung cancer	8.28e-05	0.000152	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.26e-05	0.000152	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PPP2R1B—lung cancer	8.13e-05	0.000149	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—lung cancer	8.12e-05	0.000149	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ANXA1—lung cancer	8.03e-05	0.000147	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTA1—lung cancer	7.99e-05	0.000147	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCC3—lung cancer	7.9e-05	0.000145	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ENO1—lung cancer	7.86e-05	0.000144	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—CREBBP—lung cancer	7.85e-05	0.000144	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.83e-05	0.000144	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SDC4—lung cancer	7.81e-05	0.000143	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTHLH—lung cancer	7.75e-05	0.000142	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.73e-05	0.000142	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKR1C1—lung cancer	7.65e-05	0.000141	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DUSP3—lung cancer	7.65e-05	0.00014	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—APP—lung cancer	7.61e-05	0.00014	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RHEB—lung cancer	7.5e-05	0.000138	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—UGT1A1—lung cancer	7.43e-05	0.000136	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ALB—lung cancer	7.35e-05	0.000135	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ANXA1—lung cancer	7.29e-05	0.000134	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GNG11—lung cancer	7.16e-05	0.000132	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRM8—lung cancer	7.11e-05	0.000131	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	7.07e-05	0.00013	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP2E1—lung cancer	7.05e-05	0.00013	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NQO1—lung cancer	6.97e-05	0.000128	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—POMC—lung cancer	6.96e-05	0.000128	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—lung cancer	6.93e-05	0.000127	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—APP—lung cancer	6.91e-05	0.000127	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SKI—lung cancer	6.88e-05	0.000126	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.83e-05	0.000125	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALDOA—lung cancer	6.82e-05	0.000125	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—APOA1—lung cancer	6.78e-05	0.000124	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.76e-05	0.000124	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—RAF1—lung cancer	6.65e-05	0.000122	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOA3—lung cancer	6.62e-05	0.000122	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	6.49e-05	0.000119	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ADCY1—lung cancer	6.44e-05	0.000118	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCG2—lung cancer	6.44e-05	0.000118	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ENO2—lung cancer	6.32e-05	0.000116	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HPGDS—lung cancer	6.32e-05	0.000116	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—STK11—lung cancer	6.28e-05	0.000115	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PPP2R1B—lung cancer	6.28e-05	0.000115	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTT1—lung cancer	6.13e-05	0.000113	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GCLC—lung cancer	6.06e-05	0.000111	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2A6—lung cancer	6.06e-05	0.000111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PXN—lung cancer	5.98e-05	0.00011	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AVP—lung cancer	5.92e-05	0.000109	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.9e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRP—lung cancer	5.85e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—OXTR—lung cancer	5.85e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKR1C1—lung cancer	5.85e-05	0.000108	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—lung cancer	5.81e-05	0.000107	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ENO1—lung cancer	5.74e-05	0.000105	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.74e-05	0.000105	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAT—lung cancer	5.66e-05	0.000104	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.63e-05	0.000103	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCB1—lung cancer	5.5e-05	0.000101	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNG11—lung cancer	5.48e-05	0.000101	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TYMS—lung cancer	5.41e-05	9.93e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CXCL8—lung cancer	5.38e-05	9.89e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AVP—lung cancer	5.37e-05	9.87e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	5.37e-05	9.86e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTM1—lung cancer	5.34e-05	9.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFC—lung cancer	5.22e-05	9.58e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2E1—lung cancer	5.15e-05	9.46e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NQO1—lung cancer	5.09e-05	9.35e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1A1—lung cancer	5.07e-05	9.31e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ERCC2—lung cancer	5.02e-05	9.23e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—HRAS—lung cancer	4.97e-05	9.14e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADCY1—lung cancer	4.93e-05	9.05e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	4.86e-05	8.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PPP2R1B—lung cancer	4.8e-05	8.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SMARCA4—lung cancer	4.8e-05	8.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HSPB1—lung cancer	4.63e-05	8.51e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—STK11—lung cancer	4.59e-05	8.43e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTHLH—lung cancer	4.58e-05	8.41e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—APOA1—lung cancer	4.35e-05	7.98e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ANXA1—lung cancer	4.31e-05	7.91e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—lung cancer	4.25e-05	7.8e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FLT1—lung cancer	4.17e-05	7.66e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.16e-05	7.64e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAT—lung cancer	4.13e-05	7.59e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	4.13e-05	7.59e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APP—lung cancer	4.08e-05	7.5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH3—lung cancer	4.08e-05	7.5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF9—lung cancer	4.05e-05	7.44e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCB1—lung cancer	4.02e-05	7.38e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CG—lung cancer	3.97e-05	7.29e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TYMS—lung cancer	3.95e-05	7.25e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—POMC—lung cancer	3.93e-05	7.23e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM1—lung cancer	3.9e-05	7.17e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JUNB—lung cancer	3.87e-05	7.1e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—POMC—lung cancer	3.78e-05	6.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	3.75e-05	6.89e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1A1—lung cancer	3.7e-05	6.8e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CREBBP—lung cancer	3.68e-05	6.76e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ERCC2—lung cancer	3.67e-05	6.74e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	3.63e-05	6.67e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—POMC—lung cancer	3.57e-05	6.56e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STK11—lung cancer	3.51e-05	6.45e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CD—lung cancer	3.49e-05	6.41e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6R—lung cancer	3.48e-05	6.4e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALB—lung cancer	3.44e-05	6.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FOXO3—lung cancer	3.39e-05	6.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	3.32e-05	6.1e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	3.3e-05	6.06e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AVP—lung cancer	3.18e-05	5.83e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—APOA1—lung cancer	3.17e-05	5.83e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	3.17e-05	5.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1R—lung cancer	3.06e-05	5.61e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	3.04e-05	5.59e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CB—lung cancer	3.04e-05	5.58e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—lung cancer	3.01e-05	5.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HES1—lung cancer	3e-05	5.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—RAF1—lung cancer	2.95e-05	5.41e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IL2—lung cancer	2.91e-05	5.34e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CG—lung cancer	2.9e-05	5.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	2.88e-05	5.28e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL8—lung cancer	2.76e-05	5.08e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—POMC—lung cancer	2.76e-05	5.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB3—lung cancer	2.75e-05	5.04e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CREBBP—lung cancer	2.69e-05	4.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL2—lung cancer	2.64e-05	4.85e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TERT—lung cancer	2.63e-05	4.83e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTEN—lung cancer	2.63e-05	4.83e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGFR1—lung cancer	2.55e-05	4.69e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CD—lung cancer	2.55e-05	4.68e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIF1A—lung cancer	2.52e-05	4.62e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALB—lung cancer	2.52e-05	4.62e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—EP300—lung cancer	2.51e-05	4.6e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APOA1—lung cancer	2.43e-05	4.46e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KDR—lung cancer	2.41e-05	4.42e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CB—lung cancer	2.22e-05	4.08e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CG—lung cancer	2.22e-05	4.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KIT—lung cancer	2.22e-05	4.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APC—lung cancer	2.22e-05	4.07e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NRAS—lung cancer	2.22e-05	4.07e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—lung cancer	2.2e-05	4.04e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGF—lung cancer	2.19e-05	4.02e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MAPK3—lung cancer	2.12e-05	3.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—POMC—lung cancer	2.11e-05	3.88e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BRAF—lung cancer	2.08e-05	3.83e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6R—lung cancer	2.06e-05	3.78e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CREBBP—lung cancer	2.06e-05	3.78e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EGFR—lung cancer	2.02e-05	3.71e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.96e-05	3.6e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.95e-05	3.58e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.93e-05	3.55e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTEN—lung cancer	1.92e-05	3.52e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.91e-05	3.5e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CA—lung cancer	1.85e-05	3.4e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—EP300—lung cancer	1.83e-05	3.36e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.75e-05	3.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MDM2—lung cancer	1.75e-05	3.21e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RAF1—lung cancer	1.74e-05	3.2e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.72e-05	3.16e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.7e-05	3.12e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MTOR—lung cancer	1.7e-05	3.12e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.63e-05	3e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.62e-05	2.98e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.58e-05	2.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—lung cancer	1.56e-05	2.87e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL2—lung cancer	1.56e-05	2.87e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—lung cancer	1.55e-05	2.85e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCND1—lung cancer	1.52e-05	2.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JUN—lung cancer	1.52e-05	2.79e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—lung cancer	1.51e-05	2.78e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—lung cancer	1.48e-05	2.71e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.47e-05	2.7e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTEN—lung cancer	1.47e-05	2.7e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.43e-05	2.63e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EP300—lung cancer	1.4e-05	2.57e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SRC—lung cancer	1.36e-05	2.5e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CA—lung cancer	1.35e-05	2.49e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.33e-05	2.44e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT3—lung cancer	1.31e-05	2.41e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NRAS—lung cancer	1.31e-05	2.41e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.25e-05	2.3e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MYC—lung cancer	1.22e-05	2.24e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGFR—lung cancer	1.19e-05	2.19e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KRAS—lung cancer	1.13e-05	2.07e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—lung cancer	1.11e-05	2.03e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.04e-05	1.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—lung cancer	1e-05	1.84e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HRAS—lung cancer	9.58e-06	1.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—lung cancer	9.17e-06	1.68e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—lung cancer	8.46e-06	1.55e-05	CbGpPWpGaD
